KMID : 0939920180500010129
|
|
´ëÇѾÏÇÐȸÁö 2018 Volume.50 No. 1 p.129 ~ p.137
|
|
Cancer-Specific Mortality Among Korean Men with Localized or Locally Advanced Prostate Cancer Treated with Radical Prostatectomy Versus Radiotherapy: A Multi-Center Study Using Propensity Scoring and Competing Risk Regression Analyses
|
|
Koo Kyo-Chul
Cho Jin-Seon Bang Woo-Jin Lee Seung-Hwan Cho Sung-Yong Kim Sun-Il Kim Se-Joong Rha Koon-Ho Hong Sung-Joon Chung Byung-Ha
|
|
Abstract
|
|
|
Purpose: Studies comparing radical prostatectomy (RP) outcomes with those of radiotherapy with or without androgen deprivation therapy (RT¡¾ADT) for prostate cancer (PCa) have yielded conflicting results. Therefore, we used propensity score-matched analysis and competing risk regression analysis to compare cancer-specific mortality (CSM) and other-cause mortality (OCM) between these two treatments.
Materials and Methods: The multi-center, Severance Urological Oncology Group registry was utilized to identify 3,028 patients with clinically localized or locally advanced PCa treated by RP (n=2,521) or RT¡¾ADT (n=507) between 2000 and 2016. RT¡¾ADT cases (n=339) were matched with an equal number of RP cases by propensity scoring based on age, preoperative prostate-specific antigen, clinical tumor stage, biopsy Gleason score, and Charlson Comorbidity Index (CCI). CSM and OCM were co-primary endpoints.
Results: Median follow-up was 65.0 months. Five-year overall survival rates for patients treated with RP and RT¡¾ADT were 94.7% and 92.0%, respectively (p=0.105). Cumulative incidence estimates revealed comparable CSM rates following both treatments within all National Comprehensive Cancer Network risk groups. Gleason score ¡Ã 8 was associated with higher risk of CSM (p=0.009). OCM rates were comparable between both groups in the low- and intermediate-risk categories (p=0.354 and p=0.643, respectively). For high-risk patients, RT¡¾ADT resulted in higher OCM rates than RP (p=0.011). Predictors of OCM were age ¡Ã 75 years (p=0.002) and CCI ¡Ã 2 (p < 0.001).
Conclusion: RP and RT¡¾ADT provide comparable CSM outcomes in patients with localized or locally advanced PCa. The risk of OCM may be higher for older high-risk patients with significant comorbidities.
|
|
KEYWORD
|
|
Prostatic neoplasms, Prostatectomy, Radiotherapy, Treatment outcome
|
|
FullTexts / Linksout information
|
|
|
|
Listed journal information
|
|
|